Turn Therapeutics TTRX
NASDAQ TTRX
$13.47 +0.06 (+0.45%)
As of: Sep 30, 2026 · 12:06 PM EDT

Turn Therapeutics (TTRX) Retained Earnings (2024 - 2026)

Updated

Turn Therapeutics (TTRX) reported Retained Earnings of -$29.21 million for Q2 2026.

Analysis

Turn Therapeutics (TTRX) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Turn Therapeutics posted Retained Earnings of -$22.39 million.

  • By year, Retained Earnings came in at -$19.2 million in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$23.4 million (Q1 2026), -$22.39 million (Q4 2025) and -$22.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 171.67 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -17.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 40.86 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 12.59 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -22.28 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 2.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 112.09 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 15.69 Bn
10 Turn Therapeutics 388.44 Mn 388.44 Mn - -29.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.21 Mn
Mar 31, 2026 -23.40 Mn
Dec 31, 2025 -22.39 Mn
Sep 30, 2025 -22.67 Mn
Dec 31, 2024 -19.20 Mn
API Access

Turn Therapeutics Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=TTRX&period=max&api_key=YOUR_API_KEY